August 2025

Join artist Emma Barnard for a free, all-skills-welcome creative workshop that gives voice, and form, to life with dry mouth. Explore your journey through photography, collage and a behind-the-scenes lab visit, all while connecting with others who truly understand. Date, Time & Location Who Should Attend What We’ll Offer Photography Workshop – Capturing the Invisible […]

Novartis has reported that both of its pivotal Phase III clinical trials—NEPTUNUS-1 and NEPTUNUS-2—have successfully met their primary endpoint in adults with active Sjögren’s disease. These are the first global Phase III studies to show a statistically significant reduction in disease activity in this patient group. Trial Highlights What This Means for Patients About Ianalumab